Relevant bibliographies by topics / Glycolysis / Books

Books on the topic 'Glycolysis'

To see the other types of publications on this topic, follow the link: Glycolysis.
Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Glycolysis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

N, Lithaw Paul, ed. Glycolysis: Regulation, processes, and diseases. Hauppauge, NY: Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schwartz, Laurent. Cancer — Between Glycolysis and Physical Constraint. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18543-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

United States. National Aeronautics and Space Administration., ed. Model of early self-replication based on covalent complementarity for a copolymer of glycerate-3-phosphate and glycerol-3-phosphate. San Diego, CA: Salk Institute for Biological Studies, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

United States. National Aeronautics and Space Administration., ed. Model of early self-replication based on covalent complementarity for a copolymer of glycerate-3-phosphate and glycerol-3-phosphate. San Diego, CA: Salk Institute for Biological Studies, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sloan, Denis. Glycolysis in the human hepatocellular carcinoma cell line Hep-G2. Sudbury, Ont: Laurentian University, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

International Workshop on Protein Glycosylation (1990 Braunschweig, Germany). Protein glycosylation: Cellular, biotechnological, and analytical aspects. Weinheim, Federal Republic of Germany: VCH, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

P, Apte Shireesh, and Sarangarajan Rangaprasad, eds. Cellular respiration and carcinogenesis. New York: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

P, Apte Shireesh, and Sarangarajan Rangaprasad, eds. Cellular respiration and carcinogenesis. New York: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Viau, François. Effects of neural activity on oxidative and glycolytic enzyme activity and myosin heavy chain expression within diaphragm muscle fibers. Sudbury, Ont: Laurentian University, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

International Symposium on Glycolytic and Mitochondrial Defects in Muscle and Nerve (1995 Osaka, Japan). International Symposium on Glycolytic and Mitochondrial Defects in Muscle and Nerve, Osaka, Japan, July 7-8, 1994 ; Osaka Sun Palace (Expo Park Senti, Suita, Osaka. Edited by Tarui Seiichirō. New York: Wiley, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Persson, Lars-Olof. Phase partitioning in analysis of weak heterogeneous enzyme: Enzyme interactions and in protein purification ; applications on Calvin-cycle enzymes from spinach chloroplasts and glycolytic enzymes from bakers' yeast. Lund: Univ., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Ferreira, Rita, Pedro Fontes Oliveira, and Rita Nogueira-Ferreira. Glycolysis. Elsevier Science & Technology Books, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Lithaw, Paul N. Glycolysis: Regulation, Processes and Diseases. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Castilho, Alexandra. Glyco-Engineering: Methods and Protocols. Springer New York, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Hung, Shang-Cheng, and Medel Manuel L. Zulueta. Glycochemical Synthesis: Strategies and Applications. Wiley & Sons, Incorporated, John, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Hung, Shang-Cheng, and Medel Manuel L. Zulueta. Glycochemical Synthesis: Strategies and Applications. Wiley & Sons, Limited, John, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Witczak, Zbigniew J., and Roman Bielski. Coupling and Decoupling of Diverse Molecular Units in Glycosciences. Springer, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Hung, Shang-Cheng, and Medel Manuel L. Zulueta. Glycochemical Synthesis: Strategies and Applications. Wiley & Sons, Limited, John, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Witczak, Zbigniew J., and Roman Bielski. Coupling and Decoupling of Diverse Molecular Units in Glycosciences. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kuhns, William, and Inka Brockhausen. Glycoproteins and Human Disease. Springer Berlin / Heidelberg, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Hung, Shang-Cheng, and Medel Manuel L. Zulueta. Glycochemical Synthesis: Strategies and Applications. Wiley & Sons, Incorporated, John, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Castilho, Alexandra. Glyco-Engineering: Methods and Protocols. Springer New York, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kuhns, William, and Inka Brockhausen. Glycoproteins and Human Disease. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Cancer: Between glycolysis and physical constraint. Berlin: Springer, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Schwartz, Laurent. Cancer - Between Glycolysis and Physical Constraint. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Ganapathy-Kanniappan, Shanmugasundaram. Advances in GAPDH Protein Analysis: A Functional and Biochemical Approach. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Ganapathy-Kanniappan, Shanmugasundaram. Advances in GAPDH Protein Analysis: A Functional and Biochemical Approach. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Holst, Otto, Patrick J. Brennan, Anthony P. Moran, and Mark von Itzstein. Microbial Glycobiology: Structures, Relevance and Applications. Elsevier Science & Technology Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Aoki-Kinoshita, Kiyoko F. Practical Guide to Using Glycomics Databases. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Aoki-Kinoshita, Kiyoko F. Practical Guide to Using Glycomics Databases. Springer, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Aoki-Kinoshita, Kiyoko F. A Practical Guide to Using Glycomics Databases. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Seidler, Norbert W. GAPDH: Biological Properties and Diversity. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Zhao, Zhizhuang. Regulation of phosphofructokinase by reversible inactivation. 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Glycolysis: Tissue-Specific Metabolic Regulation in Physio-Pathological Conditions. Elsevier Science & Technology, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Hochachka, Peter W. Living Without Oxygen. Harvard University Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Connett, Richard J. Defining hypoxia: A systems view of Vo2, glycolysis, energetics, and intracellular Po2. 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Avedisian, Lori-Ann. The effect of selected buffering agents on performance in the competitive 1600 meter run. 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Schurr, Avital, and Evelyne Gozal, eds. Glycolysis at 75: Is it Time to Tweak the First Elucidated Metabolic Pathway in History? Frontiers Media SA, 2015. http://dx.doi.org/10.3389/978-2-88919-586-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Brito-Arias, Marco. Enzymes Involved in Glycolysis, Fatty Acid and Amino Acid Biosynthesis: Active Site Mechanisms and Inhibition. Bentham Science Publishers, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Brito-Arias, Marco. Enzymes Involved in Glycolysis, Fatty Acid and Amino Acid Biosynthesis: Active Site Mechanisms and Inhibition. Bentham Science Publishers, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Brito-Arias, Marco. Enzymes Involved in Glycolysis, Fatty Acid and Amino Acid Biosynthesis: Active Site Mechanisms and Inhibition. Bentham Science Publishers, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Stafstrom, Carl E., and Thomas P. Sutula. 2-Deoxyglucose. Edited by Dominic P. D’Agostino. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190497996.003.0036.

Full text
Abstract:
Metabolic regulation of excitability is increasingly appreciated as a strategy to control seizures and reduce pathogenesis. Inhibiting or bypassing glycolysis may be one way in which the ketogenic diet suppresses seizures. 2-deoxy-D-glucose (2DG) is a glucose analog that partially inhibits glycolysis and has antiseizure effects in several acute and chronic seizure models. The mechanisms underlying the acute and chronic effects of 2DG are being investigated. Preliminary studies provide evidence that the acute anticonvulsant actions of 2DG involve activity-dependent presynaptic suppression of excitatory synaptic transmission during network synchronization. The chronic effects of 2DG entail reduction of the expression of brain-derived neurotrophic factor and its receptor, tyrosine kinase B. Preclinical toxicology studies demonstrate that 2DG has a favorable toxicity profile at doses effective for seizure protection. Currently available preclinical studies support 2DG as a novel first-in-class metabolic treatment for epilepsy with an antiglycolytic mechanism distinct from all other anticonvulsants.
APA, Harvard, Vancouver, ISO, and other styles
43

Microbial Glycobiology Structures Relevance And Applications. Academic Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Joseph David Jean Andre Bissonnette. Effects of hypocaloric feeding and high carbohydrate refeeding on in situ muscle function, glycolysis and body composition in adult rats. 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Sherwood, Dennis, and Paul Dalby. The bioenergetics of living cells. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198782957.003.0024.

Full text
Abstract:
Living systems create order, and appear to break the Second Law. This chapter explains, and resolves, this apparent paradox, drawing on the concept of coupled reactions (as introduced in Chapters 13 and 16), as mediated by ‘energy currencies’ such as ATP and NADH. The chapter then examines the key energy-capturing systems in biological systems – glycolysis and the citric acid cycle, and also photosynthesis. Topics covered include how energy is captured in the conversion of glucose to pyruvate, the mitochondrial membrane, respiration, electron transport, ATP synthase, chloroplasts and thylakoids, photosystems I and II, and the light-independent reactions of photosynthesis.
APA, Harvard, Vancouver, ISO, and other styles
46

Dalbeth, Nicola. Clinical features of gout. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198748311.003.0005.

Full text
Abstract:
About 60% of the variance in serum urate levels can be explained by inherited genetic factors, but the extent of the contribution of genetic factors to gout in the presence of hyperuricaemia is not known. Genome-wide association studies in Europeans have identified 28 loci controlling serum urate levels, although the molecular basis of the majority of these genetic associations is currently unknown. The SLC2A9 and ABCG2 renal and gut uric acid transporters have very strong effects on urate levels and the risk of gout. Other uric acid transporters (e.g. SLC22A11/OAT478, SLC22A12/URAT1) and a glycolysis gene (GCKR) are associated with urate levels. Environmental exposures such as sugar-sweetened beverages and alcohol interact with urate-associated genetic variants in an unpredictable fashion. Very little is known about the genetic control of gout in the presence of hyperuricaemia, formation of monosodium urate crystals, and the immune response.
APA, Harvard, Vancouver, ISO, and other styles
47

Veech, Richard L., and M. Todd King. Alzheimer’s Disease. Edited by Detlev Boison. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190497996.003.0026.

Full text
Abstract:
Deficits in cerebral glucose utilization in Alzheimer’s disease (AD) arise decades before cognitive impairment and accumulation of amyloid plaques and neurofibrillary tangles in brain. Addressing this metabolic deficit has greater potential in treating AD than targeting later disease processes – an approach that has failed consistently in the clinic. Cerebral glucose utilization requires numerous enzymes, many of which have been shown to decline in AD. Perhaps the most important is pyruvate dehydrogenase (PDH), which links glycolysis with the Krebs cycle and aerobic metabolism, and whose activity is greatly suppressed in AD. The unique metabolism of ketone bodies allows them to bypass the block at pyruvate dehydrogenase and restore brain metabolism. Recent studies in mouse genetic models of AD and in a human Alzheimer’s patient showed the potential of ketones in maintaining brain energetics and function. Oral ketone bodies might be a promising avenue for treatment of Alzheimer’s disease.
APA, Harvard, Vancouver, ISO, and other styles
48

Madl, Ulrike. Pathophysiology of glucose control. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0258.

Full text
Abstract:
Hyperglycaemia is a frequent phenomenon in critically-ill patients, associated with increased morbidity and mortality. Hyperglycaemia results in cellular glucose overload and toxic adverse effects of glycolysis and oxidative phosphorylation, especially in tissues with insulin-independent glucose uptake, and acute hyperglycaemia can exert a variety of negative effects. It is the main side effect of intensive insulin therapy. Both severe and moderate hypoglycaemia are independent risk factors of mortality in critically-ill patients. Prolonged hypoglycaemia induces neuronal damage, but may also have adverse cardiovascular effects. Several risk factors predispose critically-ill patients to hypoglycaemic events. Rapid glucose fluctuations may induce oxidative stress and lead to vascular damage. Glucose complexity is a marker of endogenous glucose regulation. Association between hyperglycaemia and outcome is weaker in diabetic critically-ill patients than in non-diabetic patients. Pre-admission glucose control in diabetic critically-ill patients plays a role in the response to glucose control and mortality.
APA, Harvard, Vancouver, ISO, and other styles
49

Merriman, Tony R. The genetic basis of gout. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0040.

Full text
Abstract:
An individual’s risk of gout is determined by a complex relationship between inherited genetic variants and environmental exposures. Genetic variants that control hyperuricaemia and subsequent progression to clinical gout specify pathogenic pathways that could be therapeutically targeted. Genome-wide association studies (GWAS) have provided novel insights into the pathways leading to hyperuricaemia. GWAS have identified the renal uric acid transporter SLC2A9/GLUT9 and the gut excretory molecule ABCG2, which each have very strong genetic effects in the control of urate levels and risk of gout. Histone deacetylase inhibitors are able to correct the genetically-determined ABCG2 dysfunction. Other renal uric acid transporters, such as SLC22A11/OAT4 and SLC22A12/URAT1 have been confirmed to be genetically associated with urate and the risk of gout. Genes that generate urate during glycolysis (e.g. GCKR) are also implicated. In contrast very little is known about genetic variants that control the progression from hyperuricaemia to gout with the toll-like receptor 4 gene being the only gene with replicated evidence of association.
APA, Harvard, Vancouver, ISO, and other styles
50

Gapdh Biological Properties And Diversity. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Glycolysis' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography